These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
(State or other jurisdiction of
incorporation or organization)
|
(I.R.S. Employer
Identification Number)
|
|
|
|
N/A
|
|
(Address of principal executive offices)
|
(Zip Code)
|
|
Title of Each Class
|
|
Trading Symbol(s)
|
|
Name of Each Exchange on Which Registered
|
|
|
|
|
|
Large accelerated filer
|
☐
|
Accelerated filer
|
☐
|
|
|
☒
|
Smaller reporting company
|
|
|
Emerging growth company
|
|
||
|
Page
|
|
|
EXPLANATORY NOTE
|
|
|
PART I - FINANCIAL INFORMATION
|
|
|
Item 1. Financial Statements
|
|
|
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
|
|
Item 3. Quantitative and Qualitative Disclosures About Market Risk
|
|
|
Item 4. Controls and Procedures
|
|
|
PART II - OTHER INFORMATION
|
|
|
Item 1. Legal Proceedings
|
|
|
Item 1A. Risk Factors
|
|
|
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
|
|
|
Item 3. Defaults Upon Senior Securities
|
|
|
Item 4. Mine Safety Disclosures
|
|
|
Item 5. Other Information
|
|
|
Item 6. Exhibits
|
|
|
Signatures
|
|
Page
|
|
|
Condensed Consolidated Balance Sheets as of
September 30, 2025
and
December 31, 2024
|
|
|
Condensed Consolidated Statements of Operations for the three and
nine months ended
September 30, 2025
and
September 30, 2024
|
|
|
Condensed Consolidated Statements of
Comprehensive Income (Loss)
for the three and
nine months ended
September 30, 2025
and
September 30, 2024
|
|
|
Condensed Consolidated Statements of Cash Flows for the
nine months ended
September 30, 2025
and
September 30,
2024
|
|
|
Condensed Consolidated Statements of Changes in Equity for the three and
nine months ended
September 30, 2025
and
September 30, 2024
|
|
|
Notes to Condensed Consolidated Financial Statements
|
|
September 30,
2025
|
December 31,
2024
|
||
|
Assets
|
|||
|
Current assets:
|
|||
|
Cash and cash equivalents (amounts related to consolidated variable interest entities of
$
$
|
$
|
$
|
|
|
Accounts receivable, net (amounts related to consolidated variable interest entities of
$
$
|
|
|
|
|
Inventories
|
|
|
|
|
Other current assets
|
|
|
|
|
Total current assets
|
|
|
|
|
Property, plant and equipment, net
|
|
|
|
|
Goodwill
|
|
|
|
|
Intangibles, net
|
|
|
|
|
Prepaid pension asset
|
|
|
|
|
Other non-current assets (amounts related to consolidated variable interest entities of
$
$
|
|
|
|
|
Total assets
|
$
|
$
|
|
|
Liabilities and Equity
|
|||
|
Current liabilities:
|
|||
|
Accounts payable
|
$
|
$
|
|
|
Accrued compensation and benefits
|
|
|
|
|
Current portion of debt
|
|
|
|
|
Other current liabilities
|
|
|
|
|
Total current liabilities
|
|
|
|
|
Non-current debt due after one year (amounts related to consolidated variable interest entities of
$
million
and
$
|
|
|
|
|
Deferred tax liabilities
|
|
|
|
|
Pension liabilities and other postretirement benefits, net of current portion
|
|
|
|
|
Other non-current liabilities (amounts related to consolidated variable interest entities of
$
and
$
|
|
|
|
|
Total liabilities
|
|
|
|
|
Commitments and Contingencies (Note 16)
|
|
|
|
|
Equity:
|
|||
|
Preferred stock;
$
|
|
|
|
|
Common stock;
$
shares outstanding at
September 30, 2025
and
December 31, 2024
, respectively
|
|
|
|
|
Deferred shares;
€
September 30, 2025
and
December 31, 2024
, respectively
|
|
|
|
|
Treasury stock; at cost;
December 31, 2024
, respectively
|
(
|
(
|
|
|
Capital in excess of par value
|
|
|
|
|
Accumulated other comprehensive loss
|
(
|
(
|
|
|
Retained earnings
|
|
|
|
|
Total shareholders’ equity
|
|
|
|
|
Noncontrolling interests
|
|
|
|
|
Total equity
|
|
|
|
|
Total liabilities and equity
|
$
|
$
|
|
Three months ended September 30,
|
Nine months ended September 30,
|
||||||
|
2025
|
2024
|
2025
|
2024
|
||||
|
Net sales
|
$
|
$
|
$
|
$
|
|||
|
Cost of goods sold
|
(
|
(
|
(
|
(
|
|||
|
Gross profit
|
|
|
|
|
|||
|
Selling, general and administrative expenses
|
(
|
(
|
(
|
(
|
|||
|
Impairment and restructuring costs
|
(
|
(
|
(
|
(
|
|||
|
Transaction and integration-related expenses associated with
the Combination
|
(
|
(
|
(
|
(
|
|||
|
Operating profit
|
|
|
|
|
|||
|
Pension and other postretirement non-service income
(expense), net
|
|
|
|
(
|
|||
|
Interest expense, net
|
(
|
(
|
(
|
(
|
|||
|
Other expense, net
|
(
|
(
|
(
|
(
|
|||
|
Income (loss) before income taxes
|
|
(
|
|
|
|||
|
Income tax expense
|
(
|
(
|
(
|
(
|
|||
|
Net income (loss)
|
|
(
|
|
|
|||
|
Net loss attributable to noncontrolling interests
|
|
|
|
|
|||
|
Net income (loss) attributable to common shareholders
|
$
|
$
(
|
$
|
$
|
|||
|
Basic earnings (loss) per share attributable to common
shareholders
|
$
|
$
(
|
$
|
$
|
|||
|
Diluted earnings (loss) per share attributable to common
shareholders
|
$
|
$
(
|
$
|
$
|
|||
|
The accompanying notes are an integral part of these Unaudited Condensed Consolidated Financial Statements.
|
|||||||
|
Three months ended September 30,
|
Nine months ended September 30,
|
||||||
|
2025
|
2024
|
2025
|
2024
|
||||
|
Net income (loss)
|
$
|
$
(
|
$
|
$
|
|||
|
Other comprehensive income (loss), net of tax:
|
|||||||
|
Foreign currency translation gain (loss)
|
|
|
|
(
|
|||
|
Defined benefit pension and other postretirement benefit
plans adjustments
|
|
(
|
(
|
|
|||
|
Net gain (loss) on cash flow hedges
|
|
|
(
|
|
|||
|
Other comprehensive income (loss), net of tax
|
|
|
|
(
|
|||
|
Comprehensive income (loss)
|
|
(
|
|
|
|||
|
Comprehensive loss attributable to noncontrolling interests
|
|
|
|
|
|||
|
Comprehensive income (loss) attributable to common
shareholders
|
$
|
$
(
|
$
|
$
|
|||
|
The accompanying notes are an integral part of these Unaudited Condensed Consolidated Financial Statements.
|
|||||||
|
Nine months ended September 30,
|
|||
|
2025
|
2024
|
||
|
Operating activities:
|
|||
|
Net income
|
$
|
$
|
|
|
Adjustments to reconcile consolidated net income to net cash provided by operating activities:
|
|||
|
Depreciation, depletion and amortization
|
|
|
|
|
Impairment charges
|
|
|
|
|
Cash surrender value increase in excess of premiums paid
|
(
|
(
|
|
|
Share-based compensation expense
|
|
|
|
|
Deferred income tax benefit
|
(
|
(
|
|
|
Pension and other postretirement funding more than cost
|
(
|
(
|
|
|
Other
|
|
|
|
|
Change in operating assets and liabilities, net of acquisitions and divestitures:
|
|||
|
Accounts receivable
|
(
|
(
|
|
|
Inventories
|
(
|
|
|
|
Other assets
|
(
|
(
|
|
|
Accounts payable
|
(
|
(
|
|
|
Income taxes
|
|
|
|
|
Accrued liabilities and other
|
|
|
|
|
Net cash provided by operating activities
|
|
|
|
|
Investing activities:
|
|||
|
Capital expenditures
|
(
|
(
|
|
|
Cash paid for purchase of businesses, net of cash acquired
|
(
|
(
|
|
|
Proceeds from corporate owned life insurance
|
|
|
|
|
Proceeds from sale of property, plant and equipment
|
|
|
|
|
Other
|
|
|
|
|
Net cash used for investing activities
|
(
|
(
|
|
|
Financing activities:
|
|||
|
Additions to debt
|
|
|
|
|
Repayments of debt
|
(
|
(
|
|
|
Debt issuance costs
|
(
|
(
|
|
|
Changes in commercial paper, net
|
(
|
(
|
|
|
Other debt (repayments) additions, net
|
(
|
|
|
|
Repayments of finance lease liabilities
|
(
|
(
|
|
|
Tax paid in connection with shares withheld from employees
|
(
|
(
|
|
|
Purchases of treasury stock
|
|
(
|
|
|
Cash dividends paid to shareholders
|
(
|
(
|
|
|
Other
|
|
(
|
|
|
Net cash (used for) provided by financing activities
|
(
|
|
|
|
Effect of exchange rate changes on cash and cash equivalents
|
|
(
|
|
|
Decrease in cash and cash equivalents
|
(
|
(
|
|
|
Cash and cash equivalents at beginning of period
|
|
|
|
|
Cash and cash equivalents at end of period
|
$
|
$
|
|
|
Shares of
Common Stock
|
Common Stock
|
Capital in
Excess of Par
Value
|
Treasury Stock
|
Retained
Earnings
|
Accumulated
Other
Comprehensive
Loss
|
Total
Shareholders'
Equity
|
Noncontrolling
Interest ("NCI")
|
Total
|
|
|
Balance at June 30, 2025
|
|
$
|
$
|
$
(
|
$
|
$
(
|
$
|
$
|
$
|
|
Net income (loss)
|
—
|
—
|
—
|
—
|
|
—
|
|
(
|
|
|
Other comprehensive income, net of tax
|
—
|
—
|
—
|
—
|
—
|
|
|
—
|
|
|
Share-based compensation
|
—
|
—
|
|
—
|
—
|
—
|
|
—
|
|
|
Issuance of common stock net of tax paid in
connection with shares withheld from employees
|
—
|
—
|
|
—
|
(
|
—
|
|
—
|
|
|
Dividends declared (
$
|
—
|
—
|
|
—
|
(
|
—
|
(
|
—
|
(
|
|
Balance at September 30, 2025
|
|
$
|
$
|
$
(
|
$
|
$
(
|
$
|
$
|
$
|
|
Shares of
Common Stock
|
Common Stock
|
Capital in
Excess of Par
Value
|
Treasury Stock
|
Retained
Earnings
|
Accumulated
Other
Comprehensive
Loss
|
Total
Shareholders'
Equity
|
Noncontrolling
Interest
|
Total
|
|
|
Balance at
June 30, 2024
(1)
|
|
$
|
$
|
$
(
|
$
|
$
(
|
$
|
$
|
$
|
|
Net loss
|
—
|
—
|
—
|
—
|
(
|
—
|
(
|
—
|
(
|
|
Other comprehensive income, net of tax
|
—
|
—
|
—
|
—
|
—
|
|
|
—
|
|
|
Share-based compensation
|
—
|
—
|
|
—
|
—
|
—
|
|
—
|
|
|
Shares of Smurfit Westrock common stock issued
to WestRock shareholders and NCI assumed as a
result of the Merger
|
|
|
|
—
|
—
|
—
|
|
|
|
|
Converted WestRock restricted stock units and
stock options attributable to pre-Combination
services
|
—
|
—
|
|
—
|
—
|
—
|
|
—
|
|
|
Issuance of common stock net of tax paid in
connection with shares withheld from employees
|
|
—
|
—
|
—
|
(
|
—
|
(
|
—
|
(
|
|
Dividends declared (
$
|
—
|
—
|
|
—
|
(
|
—
|
(
|
—
|
(
|
|
Balance at September 30, 2024
|
|
$
|
$
|
$
(
|
$
|
$
(
|
$
|
$
|
$
|
|
Shares of
Common Stock
|
Common Stock
|
Capital in
Excess of Par
Value
|
Treasury Stock
|
Retained
Earnings
|
Accumulated
Other
Comprehensive
Loss
|
Total
Shareholders'
Equity
|
Noncontrolling
Interest
|
Total
|
|
|
Balance at
December 31, 2024
|
|
$
|
$
|
$
(
|
$
|
$
(
|
$
|
$
|
$
|
|
Net income (loss)
|
—
|
—
|
—
|
—
|
|
—
|
|
(
|
|
|
Other comprehensive income, net of tax
|
—
|
—
|
—
|
—
|
—
|
|
|
—
|
|
|
Share-based compensation
|
—
|
—
|
|
—
|
—
|
—
|
|
—
|
|
|
Shares distributed by Smurfit Kappa Employee
Trust
|
—
|
—
|
(
|
|
—
|
—
|
|
—
|
|
|
Issuance of common stock net of tax paid in
connection with shares withheld from employees
|
|
—
|
|
—
|
(
|
—
|
(
|
—
|
(
|
|
Cancellation of deferred shares by Smurfit Kappa
Employee Trust
|
—
|
—
|
—
|
|
(
|
—
|
|
—
|
|
|
Dividends declared ($
|
—
|
—
|
|
—
|
(
|
—
|
(
|
—
|
(
|
|
Balance at September 30, 2025
|
|
$
|
$
|
$
(
|
$
|
$
(
|
$
|
$
|
$
|
|
Shares of
Common Stock
|
Common Stock
|
Capital in
Excess of Par
Value
|
Treasury Stock
|
Retained
Earnings
|
Accumulated
Other
Comprehensive
Loss
|
Total
Shareholders'
Equity
|
Noncontrolling
Interest
|
Total
|
|
|
Balance at
December 31, 2023
(1)
|
|
$
|
$
|
$
(
|
$
|
$
(
|
$
|
$
|
$
|
|
Net income
|
—
|
—
|
—
|
—
|
|
—
|
|
—
|
|
|
Other comprehensive loss, net of tax
|
—
|
—
|
—
|
—
|
—
|
(
|
(
|
—
|
(
|
|
Share-based compensation
|
—
|
—
|
|
—
|
—
|
—
|
|
—
|
|
|
Shares distributed by Smurfit Kappa Employee
Trust
|
—
|
—
|
(
|
|
—
|
—
|
|
—
|
|
|
Purchases of treasury stock
|
—
|
—
|
—
|
(
|
—
|
—
|
(
|
—
|
(
|
|
Shares of Smurfit Westrock common stock issued
to WestRock shareholders and NCI assumed as a
result of the Merger
|
|
|
|
—
|
—
|
—
|
|
|
|
|
Converted WestRock restricted stock units and
stock options attributable to pre-Combination
services
|
—
|
—
|
|
—
|
—
|
—
|
|
—
|
|
|
Issuance of common stock net of tax paid in
connection with shares withheld from employees
|
|
—
|
—
|
—
|
(
|
—
|
(
|
—
|
(
|
|
Dividends declared (
$
|
—
|
—
|
|
—
|
(
|
—
|
(
|
—
|
(
|
|
Balance at September 30, 2024
|
|
$
|
$
|
$
(
|
$
|
$
(
|
$
|
$
|
$
|
|
Three months ended
|
Nine months ended
|
||
|
September 30, 2024
|
September 30, 2024
|
||
|
Net sales
|
$
|
$
|
|
|
Net income attributable to common shareholders
|
|
|
|
Three months ended September 30, 2025
|
North America
|
Europe, MEA
and APAC
|
LATAM
|
Total
|
|||
|
Net sales (unaffiliated customers)
|
$
|
$
|
$
|
$
|
|||
|
Add net sales (intersegment)
|
|
|
|
|
|||
|
Net sales (aggregate)
|
|
|
|
|
|||
|
Less segment expenses:
|
|||||||
|
Segment cost of goods sold
|
(
|
(
|
(
|
||||
|
Segment selling, general and administrative expenses
|
(
|
(
|
(
|
||||
|
(
|
(
|
(
|
(
|
||||
|
Segment Adjusted EBITDA
|
$
|
$
|
$
|
$
|
|||
|
Unallocated corporate costs
|
(
|
||||||
|
Depreciation, depletion and amortization
|
(
|
||||||
|
Impairment and restructuring costs
|
(
|
||||||
|
Transaction and integration-related expenses associated with
the Combination
|
(
|
||||||
|
Interest expense, net
|
(
|
||||||
|
Pension and other postretirement non-service income, net
|
|
||||||
|
Share-based compensation expense
|
(
|
||||||
|
Other expense, net
|
(
|
||||||
|
Other adjustments
|
(
|
||||||
|
Income before income taxes
|
$
|
|
Three months ended September 30, 2024
|
North America
|
Europe, MEA
and APAC
|
LATAM
|
Total
|
|||
|
Net sales (unaffiliated customers)
|
$
|
$
|
$
|
$
|
|||
|
Add net sales (intersegment)
|
|
|
|
|
|||
|
Net sales (aggregate)
|
|
|
|
|
|||
|
Less segment expenses:
|
|||||||
|
Segment cost of goods sold
|
(
|
(
|
(
|
||||
|
Segment selling, general and administrative expenses
|
(
|
(
|
(
|
||||
|
(
|
(
|
(
|
(
|
||||
|
Segment Adjusted EBITDA
|
$
|
$
|
$
|
$
|
|||
|
Unallocated corporate costs
|
(
|
||||||
|
Depreciation, depletion and amortization
|
(
|
||||||
|
Impairment and restructuring costs
|
(
|
||||||
|
Transaction and integration-related expenses associated with
the Combination
|
(
|
||||||
|
Amortization of fair value step up on inventory
|
(
|
||||||
|
Interest expense, net
|
(
|
||||||
|
Pension and other postretirement non-service income, net
|
|
||||||
|
Share-based compensation expense
|
(
|
||||||
|
Other expense, net
|
(
|
||||||
|
Other adjustments
|
(
|
||||||
|
Loss before income taxes
|
$
(
|
|
Nine months ended September 30, 2025
|
North America
|
Europe, MEA
and APAC
|
LATAM
|
Total
|
|||
|
Net sales (unaffiliated customers)
|
$
|
$
|
$
|
$
|
|||
|
Add net sales (intersegment)
|
|
|
|
|
|||
|
Net sales (aggregate)
|
|
|
|
|
|||
|
Less segment expenses:
|
|||||||
|
Segment cost of goods sold
|
(
|
(
|
(
|
||||
|
Segment selling, general and administrative expenses
|
(
|
(
|
(
|
||||
|
(
|
(
|
(
|
(
|
||||
|
Segment Adjusted EBITDA
|
$
|
$
|
$
|
$
|
|||
|
Unallocated corporate costs
|
(
|
||||||
|
Depreciation, depletion and amortization
|
(
|
||||||
|
Impairment and restructuring costs
|
(
|
||||||
|
Transaction and integration-related expenses associated with
the Combination
|
(
|
||||||
|
Interest expense, net
|
(
|
||||||
|
Pension and other postretirement non-service income, net
|
|
||||||
|
Share-based compensation expense
|
(
|
||||||
|
Other expense, net
|
(
|
||||||
|
Other adjustments
|
(
|
||||||
|
Income before income taxes
|
$
|
|
Nine months ended September 30, 2024
|
North America
|
Europe, MEA
and APAC
|
LATAM
|
Total
|
|||
|
Net sales (unaffiliated customers)
|
$
|
$
|
$
|
$
|
|||
|
Add net sales (intersegment)
|
|
|
|
|
|||
|
Net sales (aggregate)
|
|
|
|
|
|||
|
Less segment expenses:
|
|||||||
|
Segment cost of goods sold
|
(
|
(
|
(
|
||||
|
Segment selling, general and administrative expenses
|
(
|
(
|
(
|
||||
|
(
|
(
|
(
|
(
|
||||
|
Segment Adjusted EBITDA
|
$
|
$
|
$
|
$
|
|||
|
Unallocated corporate costs
|
(
|
||||||
|
Depreciation, depletion and amortization
|
(
|
||||||
|
Impairment and restructuring costs
|
(
|
||||||
|
Transaction and integration-related expenses associated with
the Combination
|
(
|
||||||
|
Amortization of fair value step up on inventory
|
(
|
||||||
|
Interest expense, net
|
(
|
||||||
|
Pension and other postretirement non-service expense, net
|
(
|
||||||
|
Share-based compensation expense
|
(
|
||||||
|
Other expense, net
|
(
|
||||||
|
Other adjustments
|
|
||||||
|
Income before income taxes
|
$
|
|
Nine months ended September 30,
|
|||
|
2025
|
2024
|
||
|
Capital expenditures:
|
|||
|
North America
|
$
|
$
|
|
|
Europe, MEA and APAC
|
|
|
|
|
LATAM
|
|
|
|
|
Total reportable segments
|
|
|
|
|
Corporate
|
|
|
|
|
Total capital expenditures
|
$
|
$
|
|
|
September 30,
|
December 31,
|
||
|
2025
|
2024
|
||
|
Assets:
|
|||
|
North America
|
$
|
$
|
|
|
Europe, MEA and APAC
|
|
|
|
|
LATAM
|
|
|
|
|
Total reportable segments
|
|
|
|
|
Corporate
(1)
|
|
|
|
|
Total assets
|
$
|
$
|
|
Three months ended September 30, 2025
|
|||||||
|
North America
|
Europe, MEA
and APAC
|
LATAM
|
Total
|
||||
|
Revenue by product:
|
|||||||
|
Paper
|
$
|
$
|
$
|
$
|
|||
|
Packaging
|
|
|
|
|
|||
|
Total
|
$
|
$
|
$
|
$
|
|||
|
Three months ended September 30, 2024
|
|||||||
|
North America
|
Europe, MEA
and APAC
|
LATAM
|
Total
|
||||
|
Revenue by product:
|
|||||||
|
Paper
|
$
|
$
|
$
|
$
|
|||
|
Packaging
|
|
|
|
|
|||
|
Total
|
$
|
$
|
$
|
$
|
|||
|
Nine months ended September 30, 2025
|
|||||||
|
North America
|
Europe, MEA
and APAC
|
LATAM
|
Total
|
||||
|
Revenue by product:
|
|||||||
|
Paper
|
$
|
$
|
$
|
$
|
|||
|
Packaging
|
|
|
|
|
|||
|
Total
|
$
|
$
|
$
|
$
|
|||
|
Nine months ended September 30, 2024
|
|||||||
|
North America
|
Europe, MEA
and APAC
|
LATAM
|
Total
|
||||
|
Revenue by product:
|
|||||||
|
Paper
|
$
|
$
|
$
|
$
|
|||
|
Packaging
|
|
|
|
|
|||
|
Total
|
$
|
$
|
$
|
$
|
|||
|
Three months ended September 30,
|
Nine months ended September 30,
|
||||||
|
|
2025
|
2024
|
2025
|
2024
|
|||
|
Impairment charges
|
$
|
$
|
$
|
$
|
|||
|
Restructuring costs
|
|
|
|
|
|||
|
Impairment and restructuring costs
|
$
|
$
|
$
|
$
|
|||
|
Three months ended September 30,
|
Nine months ended September 30,
|
||||||
|
|
2025
|
2024
|
2025
|
2024
|
|||
|
Impairment of property, plant and equipment
|
$
|
$
|
$
|
$
|
|||
|
Impairment of other assets
|
|
|
|
|
|||
|
Total impairment charges
|
$
|
$
|
$
|
$
|
|||
|
Three months ended September 30,
|
Nine months ended September 30,
|
||||||
|
2025
|
2024
|
2025
|
2024
|
||||
|
North America
|
$
|
$
|
$
|
$
|
|||
|
Europe, MEA and APAC
|
|
|
|
|
|||
|
LATAM
|
|
|
|
|
|||
|
Total impairment charges recognized for property, plant
and equipment
|
$
|
$
|
$
|
$
|
|||
|
Three months ended September 30,
|
Nine months ended September 30,
|
||||||
|
2025
|
2024
|
2025
|
2024
|
||||
|
North America
|
$
|
$
|
$
|
$
|
|||
|
Europe, MEA and APAC
|
|
|
|
|
|||
|
LATAM
|
|
|
|
|
|||
|
Total restructuring costs
|
$
|
$
|
$
|
$
|
|||
|
Three months ended September 30,
|
Nine months ended September 30,
|
||||||
|
|
2025
|
2024
|
2025
|
2024
|
|||
|
Severance charges
|
$
|
$
|
$
|
$
|
|||
|
Other costs
|
|
|
|
|
|||
|
Total restructuring costs
|
$
|
$
|
$
|
$
|
|||
|
Severance charges
|
Other costs
|
Total
|
|||
|
Balance at December 31, 2024
|
$
|
$
|
$
|
||
|
Charges for the period
|
|
|
|
||
|
Payments
|
(
|
(
|
(
|
||
|
Balance at September 30, 2025
|
$
|
$
|
$
|
|
Three months ended September 30,
|
Nine months ended September 30,
|
||||||
|
2025
|
2024
|
2025
|
2024
|
||||
|
Transaction-related expenses associated with the
Combination
|
$
|
$
(
|
$
|
$
(
|
|||
|
Integration-related expenses associated with the
Combination
|
(
|
(
|
(
|
(
|
|||
|
Total transaction and integration-related expenses
associated with the Combination
|
$
(
|
$
(
|
$
(
|
$
(
|
|||
|
September 30,
|
December 31,
|
||
|
2025
|
2024
|
||
|
Gross accounts receivable
|
$
|
$
|
|
|
Less: Allowances
|
(
|
(
|
|
|
Accounts receivable, net
|
$
|
$
|
|
September 30,
|
December 31,
|
||
|
2025
|
2024
|
||
|
Finished goods
|
$
|
$
|
|
|
Work-in-progress
|
|
|
|
|
Raw materials
|
|
|
|
|
Consumables and spare parts
|
|
|
|
|
Inventories
|
$
|
$
|
|
September 30,
|
December 31,
|
||
|
2025
|
2024
|
||
|
Land and buildings
|
$
|
$
|
|
|
Plant and equipment
|
|
|
|
|
Construction-in-progress
|
|
|
|
|
Finance lease right-of-use assets
|
|
|
|
|
Property, plant and equipment at cost, excluding forestlands
|
|
|
|
|
Less: Accumulated depreciation and impairment
|
(
|
(
|
|
|
Property, plant and equipment, net, excluding forestlands
|
|
|
|
|
Forestlands, net of depletion
|
|
|
|
|
Property, plant and equipment, net
|
$
|
$
|
|
Three months ended September 30,
|
Nine months ended September 30,
|
||||||
|
2025
|
2024
|
2025
|
2024
|
||||
|
Interest expense
|
$
(
|
$
(
|
$
(
|
$
(
|
|||
|
Interest income
|
|
|
|
|
|||
|
Interest expense, net
|
$
(
|
$
(
|
$
(
|
$
(
|
|||
|
September 30, 2025
|
December 31, 2024
|
||||||
|
Book Value
|
Fair Value
|
Book Value
|
Fair Value
|
||||
|
Debt with fixed interest rates
|
$
|
$
|
$
|
$
|
|||
|
Level 1
|
Level 2
|
||||||
|
September 30,
|
December 31,
|
September 30,
|
December 31,
|
||||
|
2025
|
2024
|
2025
|
2024
|
||||
|
Assets
|
|||||||
|
Other Investments:
|
|||||||
|
Listed
|
$
|
$
|
$
|
$
|
|||
|
Unlisted
|
|
|
|
|
|||
|
Derivatives in cash flow hedging relationships
|
|
|
|
|
|||
|
Derivatives not designated as hedging instruments
|
|
|
|
|
|||
|
Assets measured at fair value
|
$
|
$
|
$
|
$
|
|||
|
|
|||||||
|
Liabilities
|
|||||||
|
Derivatives in cash flow hedging relationships
|
$
|
$
|
$
|
$
|
|||
|
Derivatives not designated as hedging instruments
|
|
|
|
|
|||
|
Liabilities measured at fair value
|
$
|
$
|
$
|
$
|
|||
|
Nine months ended September 30,
|
|||
|
2025
|
2024
|
||
|
Receivable from financial institutions at January 1
|
$
|
$
|
|
|
Receivables sold to the financial institutions and derecognized
|
(
|
(
|
|
|
Receivables collected by financial institutions
|
|
|
|
|
Cash (payments to) proceeds from financial institutions
|
(
|
|
|
|
Receivable from financial institutions at September 30
|
$
|
$
|
|
|
|
September 30,
|
December 31,
|
|
|
2025
|
2024
|
||
|
$
|
$
|
$
|
|
|
$
|
|
|
|
|
$
|
|
|
|
|
€
|
|
|
|
|
$
|
|
|
|
|
$
|
|
|
|
|
€
|
|
|
|
|
€
|
|
|
|
|
€
|
|
|
|
|
$
|
|
|
|
|
$
|
|
|
|
|
$
|
|
|
|
|
$
|
|
|
|
|
$
|
|
|
|
|
$
|
|
|
|
|
€
|
|
|
|
|
€
|
|
|
|
|
$
|
|
|
|
|
$
|
|
|
|
|
$
|
|
|
|
|
€
|
|
|
|
|
$
|
|
|
|
|
$
|
|
|
|
|
$
|
|
|
|
|
Commercial paper
|
|
|
|
|
Vendor financing and commercial card programs
|
|
|
|
|
Term loan facilities
|
|
|
|
|
Bank loans
|
|
|
|
|
Finance lease obligations
|
|
|
|
|
Bank overdrafts
|
|
|
|
|
Total debt, excluding debt issuance costs
|
|
|
|
|
Debt issuance costs
|
(
|
(
|
|
|
Total debt
|
|
|
|
|
Less: Current portion of debt
|
(
|
(
|
|
|
Non-current debt due after one year
|
$
|
$
|
|
Defined Benefit Pension Plans
|
Defined Benefit Pension Plans
|
||||||||||||||
|
U.S. Plans
|
Non-U.S. Plans
|
U.S. Plans
|
Non-U.S. Plans
|
||||||||||||
|
Three months ended September 30,
|
Nine months ended September 30,
|
||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
2025
|
2024
|
2025
|
2024
|
||||||||
|
Service cost
|
$
|
$
|
$
|
$
|
$
|
$
|
$
|
$
|
|||||||
|
Interest cost
|
|
|
|
|
|
|
|
|
|||||||
|
Expected return on assets
|
(
|
(
|
(
|
(
|
(
|
(
|
(
|
(
|
|||||||
|
Amortization of:
|
|||||||||||||||
|
Net actuarial loss
|
|
|
|
|
|
|
|
|
|||||||
|
Prior service credit
|
|
|
|
(
|
|
|
(
|
(
|
|||||||
|
Settlement loss
|
|
|
|
|
|
|
|
|
|||||||
|
Net periodic benefit
(income) cost
|
$
(
|
$
(
|
$
|
$
|
$
(
|
$
(
|
$
|
$
|
|||||||
|
Other Postretirement Benefit Plans
|
Other Postretirement Benefit Plans
|
||||||
|
Three months ended September 30,
|
Nine months ended September 30,
|
||||||
|
2025
|
2024
|
2025
|
2024
|
||||
|
Service cost
|
$
|
$
|
$
|
$
|
|||
|
Interest cost
|
|
|
|
|
|||
|
Amortization of:
|
|||||||
|
Net actuarial loss
|
(
|
|
(
|
|
|||
|
Net periodic benefit cost
|
$
|
$
|
$
|
$
|
|||
|
Three months ended September 30,
|
Nine months ended September 30,
|
||||||
|
2025
|
2024
|
2025
|
2024
|
||||
|
Numerator:
|
|||||||
|
Net income (loss) attributable to common shareholders
|
$
|
$
(
|
$
|
$
|
|||
|
Denominator:
|
|||||||
|
Basic weighted average shares outstanding
|
|
|
|
|
|||
|
Effect of dilutive share options
|
|
|
|
|
|||
|
Diluted weighted average shares outstanding
|
|
|
|
|
|||
|
Basic earnings (loss) per share attributable to common
shareholders
|
$
|
$
(
|
$
|
$
|
|||
|
Diluted earnings (loss) per share attributable to common
shareholders
|
$
|
$
(
|
$
|
$
|
|||
|
Three months ended September 30,
|
Nine months ended September 30,
|
||||||
|
2025
|
2024
|
2025
|
2024
|
||||
|
Performance stock units
|
|
|
|
|
|||
|
Restricted stock units
|
|
|
|
|
|||
|
Total antidilutive shares
|
|
|
|
|
|||
|
September 30,
|
December 31,
|
||
|
2025
|
2024
|
||
|
Assets
|
|||
|
Current assets:
|
|||
|
Cash and cash equivalents
|
$
|
$
|
|
|
Accounts receivable
|
|
|
|
|
Other current assets
|
|
|
|
|
Non-current assets:
|
|||
|
Property, plant and equipment, net
|
|
|
|
|
Other non-current assets
|
|
|
|
|
Total assets
|
$
|
$
|
|
|
Liabilities
|
|||
|
Current liabilities:
|
|||
|
Accounts payable
|
$
|
$
|
|
|
Current portion of debt
|
|
|
|
|
Other current liabilities
|
|
|
|
|
Non-current liabilities:
|
|||
|
Non-current debt due after one year
|
|
|
|
|
Other non-current liabilities
|
|
|
|
|
Total liabilities
|
$
|
$
|
|
Foreign Currency
Translation
|
Cash Flow
Hedges
|
Defined Benefit
Pension and Other
Postretirement
Benefit Plans
|
Other Reserves
(1)
|
Total
(2)
|
|
|
Balance at June 30, 2024
|
$
|
$
|
$
|
$
(
|
$
|
|
Other comprehensive (income) loss
|
(
|
|
|
|
(
|
|
Balance at September 30, 2024
|
$
|
$
|
$
|
$
(
|
$
|
|
Balance at June 30, 2025
|
$
|
$
|
$
|
$
(
|
$
|
|
Other comprehensive income
|
(
|
(
|
(
|
|
(
|
|
Balance at September 30, 2025
|
$
|
$
|
$
|
$
(
|
$
|
|
Foreign Currency
Translation
|
Cash Flow
Hedges
|
Defined Benefit
Pension and Other
Postretirement
Benefit Plans
|
Other Reserves
(1)
|
Total
(2)
|
|
|
Balance at December 31, 2023
|
$
|
$
|
$
|
$
(
|
$
|
|
Other comprehensive loss (income)
|
|
(
|
(
|
|
|
|
Balance at September 30, 2024
|
$
|
$
|
$
|
$
(
|
$
|
|
Balance at December 31, 2024
|
$
|
$
|
$
|
$
(
|
$
|
|
Other comprehensive (income) loss
|
(
|
|
|
|
(
|
|
Balance at September 30, 2025
|
$
|
$
|
$
|
$
(
|
$
|
|
Three months ended September 30,
|
|||||||
|
2025
|
2024
|
||||||
|
Pre-Tax
|
Tax
|
Net of
Tax
|
Pre-Tax
|
Tax
|
Net of
Tax
|
||
|
Foreign currency translation gain
|
$
|
$
|
$
|
$
|
$
|
$
|
|
|
Defined benefit pension and other postretirement benefit plans:
|
|||||||
|
Amortization and settlement recognition of net actuarial loss
|
|
(
|
|
|
(
|
|
|
|
Amortization of prior service credit
|
|
|
|
(
|
|
(
|
|
|
Foreign currency gain (loss) - pensions
|
|
|
|
(
|
|
(
|
|
|
Changes in fair value of cash flow hedges
|
|
|
|
|
|
|
|
|
Consolidated other comprehensive income
|
|
(
|
|
|
(
|
|
|
|
Other comprehensive income attributable to noncontrolling interests
|
|
|
|
|
|
|
|
|
Other comprehensive income attributable to common shareholders
|
$
|
$
(
|
$
|
$
|
$
(
|
$
|
|
|
Nine months ended September 30,
|
|||||||
|
2025
|
2024
|
||||||
|
Pre-Tax
|
Tax
|
Net of
Tax
|
Pre-Tax
|
Tax
|
Net of
Tax
|
||
|
Foreign currency translation gain (loss)
|
$
|
$
|
$
|
$
(
|
$
|
$
(
|
|
|
Defined benefit pension and other postretirement benefit plans:
|
|||||||
|
Net actuarial loss arising during period
|
(
|
|
(
|
(
|
|
(
|
|
|
Amortization and settlement recognition of net actuarial loss
|
|
(
|
|
|
(
|
|
|
|
Prior service cost arising during period
|
(
|
|
(
|
|
|
|
|
|
Amortization of prior service credit
|
(
|
|
(
|
(
|
|
(
|
|
|
Foreign currency loss - pensions
|
(
|
|
(
|
(
|
|
(
|
|
|
Changes in fair value of cash flow hedges
|
(
|
|
(
|
|
|
|
|
|
Consolidated other comprehensive income (loss)
|
|
|
|
(
|
(
|
(
|
|
|
Other comprehensive income attributable to noncontrolling interests
|
|
|
|
|
|
|
|
|
Other comprehensive income (loss) attributable to common shareholders
|
$
|
$
|
$
|
$
(
|
$
(
|
$
(
|
|
|
Three months ended September 30,
|
Nine months ended September 30,
|
||||||
|
2025
|
2024
|
2025
|
2024
|
||||
|
Net sales
|
$
8,003
|
$
7,671
|
$
23,599
|
$
13,570
|
|||
|
Cost of goods sold
|
(6,434)
|
(6,321)
|
(18,938)
|
(10,817)
|
|||
|
Gross profit
|
1,569
|
1,350
|
4,661
|
2,753
|
|||
|
Selling, general and administrative expenses
|
(963)
|
(1,007)
|
(2,899)
|
(1,776)
|
|||
|
Impairment and restructuring costs
|
(65)
|
(21)
|
(360)
|
(21)
|
|||
|
Transaction and integration-related expenses associated with
the Combination
|
(15)
|
(267)
|
(72)
|
(350)
|
|||
|
Operating profit
|
526
|
55
|
1,330
|
606
|
|||
|
Pension and other postretirement non-service income
(expense), net
|
8
|
8
|
24
|
(31)
|
|||
|
Interest expense, net
|
(177)
|
(167)
|
(526)
|
(225)
|
|||
|
Other expense, net
|
(21)
|
(13)
|
(44)
|
(13)
|
|||
|
Income (loss) before income taxes
|
336
|
(117)
|
784
|
337
|
|||
|
Income tax expense
|
(91)
|
(33)
|
(183)
|
(164)
|
|||
|
Net income (loss)
|
245
|
(150)
|
601
|
173
|
|||
|
Net loss attributable to noncontrolling interests
|
1
|
—
|
1
|
—
|
|||
|
Net income (loss) attributable to common shareholders
|
$
246
|
$
(150)
|
$
602
|
$
173
|
|||
|
Three months ended September 30,
|
Nine months ended September 30,
|
||||||
|
2025
|
2024
|
2025
|
2024
|
||||
|
Net sales (aggregate):
(1)
|
|||||||
|
North America
|
$
4,721
|
$
4,649
|
$
14,145
|
$
5,499
|
|||
|
Europe, MEA and APAC
|
2,831
|
2,651
|
8,191
|
7,056
|
|||
|
LATAM
|
545
|
506
|
1,576
|
1,187
|
|||
|
Segment Adjusted EBITDA:
|
|||||||
|
North America
|
$
810
|
$
780
|
$
2,347
|
$
900
|
|||
|
Europe, MEA and APAC
|
419
|
411
|
1,180
|
1,158
|
|||
|
LATAM
|
116
|
116
|
354
|
257
|
|||
|
Nine months ended September 30,
|
|||
|
2025
|
2024
|
||
|
Net cash provided by operating activities
|
$
2,197
|
$
702
|
|
|
Net cash used for investing activities
|
$
(1,564)
|
$
(1,595)
|
|
|
Net cash (used for) provided by financing activities
|
$
(674)
|
$
869
|
|
|
Three months ended September 30,
|
Nine months ended September 30,
|
||||||
|
2025
|
2024
|
2025
|
2024
|
||||
|
Net income (loss)
|
$
245
|
$
(150)
|
$
601
|
$
173
|
|||
|
Income tax expense
|
91
|
33
|
183
|
164
|
|||
|
Depreciation, depletion and amortization
|
659
|
564
|
1,875
|
872
|
|||
|
Impairment and restructuring costs
|
65
|
21
|
360
|
21
|
|||
|
Transaction and integration-related expenses associated with
the Combination
|
15
|
267
|
72
|
350
|
|||
|
Amortization of fair value step up on inventory
|
—
|
227
|
—
|
227
|
|||
|
Interest expense, net
|
177
|
167
|
526
|
225
|
|||
|
Pension and other postretirement non-service (income)
expense, net
|
(8)
|
(8)
|
(24)
|
31
|
|||
|
Share-based compensation expense
|
35
|
123
|
114
|
154
|
|||
|
Other expense, net
|
21
|
13
|
44
|
13
|
|||
|
Other adjustments
|
2
|
8
|
16
|
(10)
|
|||
|
Adjusted EBITDA
|
$
1,302
|
$
1,265
|
$
3,767
|
$
2,220
|
|||
|
SUMMARIZED STATEMENT OF OPERATIONS
|
Nine months ended
September 30,
|
|
2025
|
|
|
Net sales to unrelated parties
|
$
1,100
|
|
Net sales to Non-Obligor Subsidiaries
|
909
|
|
Gross profit
|
697
|
|
Interest expense, net with unrelated parties
|
(464)
|
|
Interest expense, net with Non-Obligor Subsidiaries
|
(253)
|
|
Net income and net income attributable to the Obligor Group
|
291
|
|
SUMMARIZED BALANCE SHEETS
|
September 30,
|
December 31,
|
|
|
2025
|
2024
|
||
|
ASSETS
|
|||
|
Current amounts due from Non-Obligor Subsidiaries
|
$
5,617
|
$
4,925
|
|
|
Other current assets
|
920
|
1,049
|
|
|
Total current assets
|
$
6,537
|
$
5,974
|
|
|
Non-current amounts due from Non-Obligor Subsidiaries
|
$
2,938
|
$
2,848
|
|
|
Other non-current assets
|
384
|
370
|
|
|
Total non-current assets
|
$
3,322
|
$
3,218
|
|
|
LIABILITIES
|
|||
|
Current amounts due to Non-Obligor Subsidiaries
|
$
8,320
|
$
9,681
|
|
|
Other current liabilities
|
999
|
1,122
|
|
|
Total current liabilities
|
$
9,319
|
$
10,803
|
|
|
Non-current amounts due to Non-Obligor Subsidiaries
|
$
6,467
|
$
6,604
|
|
|
Other non-current liabilities
|
11,683
|
9,644
|
|
|
Total non-current liabilities
|
$
18,150
|
$
16,248
|
|
Period
|
Total Number of
Shares Purchased
(1)
|
Average Price
Paid per Share
|
Total Number of
Shares Purchased
as Part of Publicly
Announced
Programs
|
Approximate
Dollar Value of
Shares that May Yet
Be Purchased
Under the Programs
|
|||
|
July 1, 2025 – July 31, 2025
|
822
|
$
43.00
|
—
|
—
|
|||
|
August 1, 2025 – August 31, 2025
|
—
|
—
|
—
|
—
|
|||
|
September 1, 2025 – September 30, 2025
|
—
|
—
|
—
|
—
|
|||
|
Total
|
822
|
—
|
|
Exhibit
Number
|
Description of Exhibit
|
||
|
3.1
|
|||
|
10.1†+
|
|||
|
22
|
|||
|
31.1†
|
|||
|
31.2†
|
|||
|
32†*
|
|||
|
101.INS
|
Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL
tags are embedded within the Inline XBRL document.**
|
||
|
101.SCH
|
Inline XBRL Taxonomy Extension Schema.**
|
||
|
101.CAL
|
Inline XBRL Taxonomy Extension Calculation Linkbase.**
|
||
|
101.DEF
|
Inline XBRL Taxonomy Extension Definition Document.**
|
||
|
101.LAB
|
Inline XBRL Taxonomy Extension Label Linkbase.**
|
||
|
101.PRE
|
Inline XBRL Taxonomy Extension Presentation Linkbase.**
|
||
|
104
|
Cover Page Interactive Data File––the cover page interactive data file does not appear in the Interactive Data File
because its XBRL tags are embedded within the Inline XBRL document.
|
|
Smurfit Westrock plc
|
||
|
Dated:
November 7, 2025
|
/s/ Anthony Smurfit
|
|
|
Name:
|
Anthony Smurfit
|
|
|
Title:
|
President & Group Chief Executive Officer
|
|
|
(Principal Executive Officer)
|
||
|
Smurfit Westrock plc
|
||
|
Dated:
November 7, 2025
|
/s/ Ken Bowles
|
|
|
Name:
|
Ken Bowles
|
|
|
Title:
|
Executive Vice President & Group Chief Financial Officer
|
|
|
(Principal Financial Officer)
|
||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|